Sequencia Corporation – Trademark Portfolio
Entity Type: 03
Sequencia Corporation holds 24 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 16 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include EPROCEDURE. The owner is based in Phoenix, AZ.
15458B North 28th Avenue
Phoenix, AZ 85053
Showing of trademarks Trademarks
Trademark Classifications
Sequencia Corporation's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Scientific and technological services; industrial analysis and research services
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does Sequencia Corporation have?
Sequencia Corporation has 24 U.S. trademarks filed with the USPTO. Of these, 1 registered, 12 abandoned, 11 cancelled.
What trademark classes does Sequencia Corporation file in?
Sequencia Corporation files trademarks across 3 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are Sequencia Corporation's most well-known trademarks?
Sequencia Corporation's registered trademark portfolio includes well-known marks such as EPROCEDURE. These are among 1 currently registered trademark in the portfolio.
What is Sequencia Corporation's trademark registration success rate?
Sequencia Corporation has a 4% trademark registration rate, with 1 out of 24 resolved applications resulting in successful registration. Currently, 0 applications are pending review.